Exact Sciences Faces Shareholder Lawsuits Over Abbott Merger
at www.tipranks.com (Tue, 10-Feb 4:39 PM)
EXAS Faces Shareholder Scrutiny Over Abbott Buyout—Is the $105 Cash Offer Truly Fair?
Market Chameleon (Thu, 20-Nov 9:55 AM)
Abbott’s $21 Billion Acquisition of Exact Sciences Signals New Era in Cancer Diagnostics
Market Chameleon (Thu, 20-Nov 8:00 AM)
